MD · Oncology · Hematology · Consulting
Combining clinical precision with a forward-thinking approach to cancer care, research collaboration, and healthcare innovation. Open to consulting, advisory, and speaking roles across pharma and medtech.
As a dual-trained oncologist and hematologist, I bring a uniquely integrated perspective to complex, overlapping presentations — and to the teams, companies, and research groups I work with.
Diagnosis and treatment of solid tumors, systemic therapy, targeted agents, and immunotherapy — delivering evidence-based, patient-centered care.
Management of blood cancers including leukemia, lymphoma, myeloma, and complex benign hematological conditions requiring specialist input.
Active participant in tumor boards and MDT meetings, contributing oncology and hematology insight to complex case discussions.
Extensive experience in enrolling and managing patients in phase I–III oncology trials, with hands-on protocol adherence and safety oversight.
I'm actively available for consulting, advisory board participation, speaking engagements, and strategic collaboration with pharmaceutical, biotech, and healthcare organisations looking for sharp oncology and hematology expertise.
Clinical input on drug development, trial design, indication strategy, and regulatory pathway navigation.
Independent clinical perspective for pharma and medtech advisory panels, launch preparations, and medical education.
Consulting for healthcare businesses on oncology pathway design, service development, and market access.
Available for conference presentations, grand rounds, symposia, and thought leadership events across hematology and oncology.
Educational content development and key opinion leader activities across hematology and oncology topics.
Grounded in active clinical practice, my research interests span novel therapeutics, translational oncology, and real-world outcomes. I welcome collaboration through my clinic and am open to investigator-initiated and industry-sponsored research partnerships.
Patients at my clinic can access a range of active oncology and hematology trials.
Open to collaborative and IIT opportunities — reach out to discuss feasibility.
Experience working with pharmaceutical partners on sponsored research programmes.
Whether you're a pharmaceutical company exploring advisory input, a healthcare business seeking oncology expertise, a research group looking for a collaborating clinician, or a conference seeking a speaker — I'd love to hear from you.